The company plans to rapidly start the production of this device.
“It is a great achievement by our team as we believe this is the first time FDA clearance is obtained for an implantable device made by MIM,” said the company’s President and CEO Yvan Beaudoin. “It is also very encouraging as Maetta is currently involved in the development of several implantable devices with various clients.”
More Articles on Devices:
FDA Clears Renovis Surgical’s Tesera Anterior Lumbar Interbody Fusion Cage
Device Companies — 7 Key Notes — Biomet, MAKO Surgical & More
46 Spine & Orthopedic Devices Receive FDA 510(k) Clearance in October
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
